TriangleNCT05655546 · OUTCOME
Number of Participants With Hospitalizations Including COVID Medications
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- During study participation (on average 12 months)
What was measured
In claims data COVID hospital admissions were defined as: claim type is "HOSP" or "Institutional" or location display contains "inpatient" with COVID diagnosis or COVID procedure or COVID medication in the same medical episode. In survey data, participants were asked to self-report COVID hospitalizations.
Groups in this outcome
Intervention Arm
Participants in this group will complete the baseline study activities, as described above. Additionally, participants will be instructed to create a Cue Health account and download the Cue Health App. Using the app and the 10 Cue Health COVID-19 molecular tests that are provided (or Cue Health Flu+COVID molecular tests if available and FDA authorized), the participant will perform tests after exposure or if symptoms arise. Participants can also use the test for close contacts who are exposed to COVID-19 and/or have symptoms. If COVID-19 infection occurs, participants will have access to telemedicine to discuss further with a healthcare professional. When clinically indicated, medication for the treatment of COVID-19 (and/or Influenza in case of Cue Health Flu+COVID test availability) will be prescribed and delivered to the participants' delivery address. Participants can also seek care through other healthcare providers or not seek care, at their discretion.
Control Arm
Participants in the control group will complete the baseline study activities, as described above. If symptoms arise or COVID-19 infection occurs, participants will test and seek care as they normally would.
| Group | Source count |
|---|---|
| Intervention Arm | 310 |
| Control Arm | 285 |
Reported measurements
Source class 1
COVID medication
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Intervention Arm | 59 | Not reported | Not reported | Not reported | Not reported |
| Control Arm | 58 | Not reported | Not reported | Not reported | Not reported |
COVID hospitalization
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Intervention Arm | 15 | Not reported | Not reported | Not reported | Not reported |
| Control Arm | 22 | Not reported | Not reported | Not reported | Not reported |
COVID ICU stay
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Intervention Arm | 1 | Not reported | Not reported | Not reported | Not reported |
| Control Arm | 13 | Not reported | Not reported | Not reported | Not reported |
No COVID infection reported
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Intervention Arm | 235 | Not reported | Not reported | Not reported | Not reported |
| Control Arm | 192 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 59
- group Id
- OG001
- value
- 58
- title
- COVID medication
- measurements
- group Id
- OG000
- value
- 15
- group Id
- OG001
- value
- 22
- title
- COVID hospitalization
- measurements
- group Id
- OG000
- value
- 1
- group Id
- OG001
- value
- 13
- title
- COVID ICU stay
- measurements
- group Id
- OG000
- value
- 235
- group Id
- OG001
- value
- 192
- title
- No COVID infection reported
- denoms
- counts
- group Id
- OG000
- value
- 310
- group Id
- OG001
- value
- 285
- units
- Participants
- description
- In claims data COVID hospital admissions were defined as: claim type is "HOSP" or "Institutional" or location display contains "inpatient" with COVID diagnosis or COVID procedure or COVID medication in the same medical episode. In survey data, participants were asked to self-report COVID hospitalizations.
- groups
- description
- Participants in this group will complete the baseline study activities, as described above. Additionally, participants will be instructed to create a Cue Health account and download the Cue Health App. Using the app and the 10 Cue Health COVID-19 molecular tests that are provided (or Cue Health Flu+COVID molecular tests if available and FDA authorized), the participant will perform tests after exposure or if symptoms arise. Participants can also use the test for close contacts who are exposed to COVID-19 and/or have symptoms. If COVID-19 infection occurs, participants will have access to telemedicine to discuss further with a healthcare professional. When clinically indicated, medication for the treatment of COVID-19 (and/or Influenza in case of Cue Health Flu+COVID test availability) will be prescribed and delivered to the participants' delivery address. Participants can also seek care through other healthcare providers or not seek care, at their discretion.
- id
- OG000
- title
- Intervention Arm
- description
- Participants in the control group will complete the baseline study activities, as described above. If symptoms arise or COVID-19 infection occurs, participants will test and seek care as they normally would.
- id
- OG001
- title
- Control Arm
- param Type
- COUNT_OF_PARTICIPANTS
- reporting Status
- POSTED
- time Frame
- During study participation (on average 12 months)
- title
- Number of Participants With Hospitalizations Including COVID Medications
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice